论文信息 - Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial - 字舞流文

Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial

R. Gansevoort | M. Irazabal | C. M. Heyer | O. Devuyst | R. Perrone | J. Ouyang | F. Czerwiec | Sarah R. Senum | J. Blais | Y. Meur | P. Harris | E. Gall | Vicente E. Torres | Arlene B. Chapman